超全!糖尿病要检测的项目及时间一张表收齐了!

2021-10-26 医学论坛网内分泌 医学论坛网内分泌

收藏,学习!

糖尿病是一种慢性病,其治疗模式是通过检测导致发生糖尿病急性和慢性并发症的危险因子的水平,从而采取相应的治疗手段来对这些危险因子进行控制。

那么要控制糖尿病并发症的发生,就需要在整个糖尿病病程中对危险因子进行定期的检测,并根据危险因子的水平来调整控制措施,所以糖顾问整理了以下三个表格对需要检测的项目以及频率进行了整合,赶紧对照并收藏起来吧~

一、病史检测项目
二、体格检查检测项目
三、实验室检测项目

注:表中“√”表示主要在社区医院或综合医院或在两级医院共同完成的项目此外,糖尿病患者还需定期进行肝功能检测,常规情况下可与其他生化项目一起检查,每年检测一次。如出现异常,应转综合医院进一步检查和治疗。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1069534, encodeId=6843106953480, content=已拜读,受益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Fri Nov 12 10:36:42 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065542, encodeId=598e1065542ba, content=好的,己收!, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Sun Oct 31 16:18:21 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065541, encodeId=1850106554141, content=这个不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Sun Oct 31 16:17:40 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065318, encodeId=4a911065318a1, content=定期复诊很重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4575435284, createdName=蓝海85, createdTime=Sat Oct 30 16:55:47 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064202, encodeId=3a441064202a2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=802c5154865, createdName=146a3e14m25暂无昵称, createdTime=Tue Oct 26 22:13:20 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064199, encodeId=a9c710641996e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Tue Oct 26 22:05:05 CST 2021, time=2021-10-26, status=1, ipAttribution=)]
    2021-11-12 湘雅科教

    已拜读,受益匪浅。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1069534, encodeId=6843106953480, content=已拜读,受益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Fri Nov 12 10:36:42 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065542, encodeId=598e1065542ba, content=好的,己收!, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Sun Oct 31 16:18:21 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065541, encodeId=1850106554141, content=这个不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Sun Oct 31 16:17:40 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065318, encodeId=4a911065318a1, content=定期复诊很重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4575435284, createdName=蓝海85, createdTime=Sat Oct 30 16:55:47 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064202, encodeId=3a441064202a2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=802c5154865, createdName=146a3e14m25暂无昵称, createdTime=Tue Oct 26 22:13:20 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064199, encodeId=a9c710641996e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Tue Oct 26 22:05:05 CST 2021, time=2021-10-26, status=1, ipAttribution=)]
    2021-10-31 419040982

    好的,己收!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1069534, encodeId=6843106953480, content=已拜读,受益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Fri Nov 12 10:36:42 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065542, encodeId=598e1065542ba, content=好的,己收!, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Sun Oct 31 16:18:21 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065541, encodeId=1850106554141, content=这个不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Sun Oct 31 16:17:40 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065318, encodeId=4a911065318a1, content=定期复诊很重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4575435284, createdName=蓝海85, createdTime=Sat Oct 30 16:55:47 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064202, encodeId=3a441064202a2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=802c5154865, createdName=146a3e14m25暂无昵称, createdTime=Tue Oct 26 22:13:20 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064199, encodeId=a9c710641996e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Tue Oct 26 22:05:05 CST 2021, time=2021-10-26, status=1, ipAttribution=)]
    2021-10-31 419040982

    这个不错

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1069534, encodeId=6843106953480, content=已拜读,受益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Fri Nov 12 10:36:42 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065542, encodeId=598e1065542ba, content=好的,己收!, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Sun Oct 31 16:18:21 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065541, encodeId=1850106554141, content=这个不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Sun Oct 31 16:17:40 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065318, encodeId=4a911065318a1, content=定期复诊很重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4575435284, createdName=蓝海85, createdTime=Sat Oct 30 16:55:47 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064202, encodeId=3a441064202a2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=802c5154865, createdName=146a3e14m25暂无昵称, createdTime=Tue Oct 26 22:13:20 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064199, encodeId=a9c710641996e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Tue Oct 26 22:05:05 CST 2021, time=2021-10-26, status=1, ipAttribution=)]
    2021-10-30 蓝海85

    定期复诊很重要

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1069534, encodeId=6843106953480, content=已拜读,受益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Fri Nov 12 10:36:42 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065542, encodeId=598e1065542ba, content=好的,己收!, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Sun Oct 31 16:18:21 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065541, encodeId=1850106554141, content=这个不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Sun Oct 31 16:17:40 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065318, encodeId=4a911065318a1, content=定期复诊很重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4575435284, createdName=蓝海85, createdTime=Sat Oct 30 16:55:47 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064202, encodeId=3a441064202a2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=802c5154865, createdName=146a3e14m25暂无昵称, createdTime=Tue Oct 26 22:13:20 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064199, encodeId=a9c710641996e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Tue Oct 26 22:05:05 CST 2021, time=2021-10-26, status=1, ipAttribution=)]
    2021-10-26 146a3e14m25暂无昵称

    学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1069534, encodeId=6843106953480, content=已拜读,受益匪浅。, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Fri Nov 12 10:36:42 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065542, encodeId=598e1065542ba, content=好的,己收!, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Sun Oct 31 16:18:21 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065541, encodeId=1850106554141, content=这个不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Sun Oct 31 16:17:40 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065318, encodeId=4a911065318a1, content=定期复诊很重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4575435284, createdName=蓝海85, createdTime=Sat Oct 30 16:55:47 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064202, encodeId=3a441064202a2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=802c5154865, createdName=146a3e14m25暂无昵称, createdTime=Tue Oct 26 22:13:20 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064199, encodeId=a9c710641996e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Tue Oct 26 22:05:05 CST 2021, time=2021-10-26, status=1, ipAttribution=)]
    2021-10-26 站在塔尖

    学习了

    0

相关资讯

COVID-19 与糖尿病之间的关系

严重急性呼吸系统综合症冠状病毒 2 (SARS-CoV-2) 是 2019 年冠状病毒病 (COVID-19) 的病原体。糖尿病是 COVID-19 患者最常见的合并症之一。

J Infect Dis: 糖尿病和糖尿病前期对抗结核治疗结果的影响

糖尿病 (DM) 已经被世界卫生组织 (WHO) 认可为全球性流行疾病,这种代谢性疾病使活动性结核病 (TB) 的的发生风险增加了三倍。

Mayo Clin Proc:富含血小板血浆对慢性伤口愈合的疗效和安全性

慢性伤口是常见的慢性病之一,对老龄人口的影响很大,为患者接社会带来较大的经济负担。最常见的与伤口形成有关的疾病包括糖尿病和压力性损伤。目前的治疗方法主要是治疗潜在的疾病和做好伤口护理,以促进健康的肉芽

糖尿病刚刚确诊就得了并发症是怎么回事?(附:新、老糖尿病患者体检表)

最近遇到一位这样的糖尿病患者,在确诊糖尿病的几天后,又被告知出现了并发症。这位糖尿病患者很不明白,为什么刚被确诊糖尿病就很快出现了并发症呢?

除了吃药,加一勺ta或也能减缓糖尿病慢性肾病进展!

PLOS ONE:亚麻籽对有或无慢性肾病的糖尿病大鼠全身炎症和氧化应激的影响